Nine Chapters Capital Management’s Zimmer Biomet ZBH Stock Holding History

Nine Chapters Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-5,253	Closed	-$479K	–	565
2015 Q3	$479K	Sell	5,253 -3,502	-40%	-$351K	0.04%	578
2015 Q2	$928K	Buy	+8,755	New	+$969K	0.08%	362
2015 Q1	–	Sell	-10,918	Closed	-$1.2M	–	1156
2014 Q4	$1.2M	Sell	10,918 -4,635	-30%	-$489K	0.1%	281
2014 Q3	$1.52M	Sell	15,553 -63,345	-80%	-$6.23M	0.14%	195
2014 Q2	$7.96M	Buy	78,898 +19,570	+33%	+$1.91M	0.65%	14
2014 Q1	$5.45M	Buy	+59,328	New	+$5.47M	0.64%	18
2013 Q4	–	Sell	-10,918	Closed	-$871K	–	960
2013 Q3	$871K	Sell	10,918 -7,828	-42%	-$616K	0.1%	284
2013 Q2	$1.36M	Buy	+18,746	New	+$1.4M	0.24%	130

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nine Chapters Capital Management's ZBH Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2015, closing a stake of 5,253 shares — an estimated $479K sold.

Nine Chapters Capital Management first reported a position in ZBH in Q2 2013 and held it in 8 quarters. The position peaked at $7.96M in Q2 2014. 739 funds tracked by Wall St. Rank hold ZBH as of Q4 2015.

Nine Chapters Capital Management reported no remaining Zimmer Biomet position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 5,253 Zimmer Biomet shares in Q4 2015, an estimated $479K.
Nine Chapters Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 8 quarters.
Nine Chapters Capital Management's Zimmer Biomet position peaked at $7.96M in Q2 2014.
739 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.